• jump to: Main navigation
  • jump to: Main content
  • jump to: Footer

Callaghan Innovation
logo - print

Search form
  • home
    • For startups
      • Founder and Startup Support Programme
      • Gracefield Innovation Quarter
      • Learning for startups
      • Technology Incubator
      • Scaleup NZ - Innovation ecosystem platform
      • Startup case studies
      • New Zealand Product Accelerator (NZPA)

      All Startup services

      Time to get in touch?

      Contact us now

    • Funding
      • Student Grants
      • Guidelines and FAQs
      • R&D Tax Incentive
      • Grant Recipients
      • Archived Funding Products
      • New to R&D Grant
      • Ārohia Innovation Trailblazer Grant

      All funding services

      Time to get in touch?

      Contact us now

    • R&D technical
      solutions
      • Research and Development Solutions
      • New Zealand Product Accelerator
      • Trial a manufacturing robot
      • Te Whare a Māui - The Māori Innovation Hub
      • Gracefield Innovation Quarter
      • Measurement Standards Laboratory

      All R&D technical solution services

      Time to get in touch?

      Contact us now

    • Industries
      • CleanTech
      • Manufacturing & Industry 4.0
      • Primary industries
      • Food and Beverage
      • Māori Economy
      • Technology
      • Health

      All industries

      Time to get in touch?

      Contact us now

    • Networking &
      partnerships
      • Callaghan Innovation Labs
      • Gracefield Innovation Quarter
      • New Zealand Food Innovation Network (NZFIN)
      • HealthTech Activator
      • Māori economy
      • New Zealand Product Accelerator
      • Scaleup NZ - Innovation ecosystem platform
      • Te Whare a Māui - The Māori Innovation Hub

      All networking & partnerships services

      Time to get in touch?

      Contact us now

    • Learning
      • Lean programme
      • Capital Education workshop
      • Aronui: Industry 4.0 navigator experience
      • Digital Lean programme
      • Product360: product commercialisation
      • Beyond IP: Intangible asset management programme
      • Customer Insights for Product-Market Fit

      All learning services

      Time to get in touch?

      Contact us now

  • About
  • News and events
  • Customers
  • Careers
  • Contact
  • Subscribe

Callaghan Innovation Research Papers

Back to Research Papers

TitleSystems immunology reveals a linked IgG3–C4 response in patients with acute rheumatic fever
Publication TypeJournal Article
Year of Publication2020
AuthorsChung, A.W., Ho T.K.C., Hanson-Manful P., Tritscheller S., Raynes J.M., Whitcombe A.L., Tay M.L., McGregor R., Lorenz N., Oliver J.R., Gurney J.K., Print C.G., Wilson N.J., Martin W.J., Williamson D.A., Baker M.G., and Moreland N.J.
JournalImmunology and Cell Biology
Volume98
Issue1
Pagination12 - 21
Date Published2020
Keywordsadolescent, alternative complement pathway C3 C5 convertase, antibody response, antigen specificity, article, Blood, C reactive protein, Child, clinical trial, comparative study, complement blood level, Complement C4, complement component C4, complement factor, complement factor H, complement system, controlled study, Enzyme linked immunosorbent assay, feature selection, Female, human, Humans, humoral immunity, Immunity, Humoral, Immunoassay, immunoglobulin A, immunoglobulin blood level, immunoglobulin class, Immunoglobulin G, immunoglobulin G1, immunoglobulin G2, immunoglobulin G3, immunoglobulin G4, immunology, immunopathogenesis, inflammation, major clinical study, Male, metabolism, protein blood level, reference value, rheumatic fever
URLhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85075276216&doi=10.1111%2fimcb.12298&partnerID=40&md5=00bba7616c43ae48ff6ebdceedccd777
DOI10.1111/imcb.12298
  • Google Scholar
  • RTF

Back to top

  • For startups
  • R&D technical solutions
  • Industries
  • Networking & partnerships
  • About us
  • News and events
  • Careers
  • Customer stories
  • Contact us
  • Site map

Client login (IMS)

  • Follow on
    Facebook
  • Follow on
    Twitter
  • Connect on
    LinkedIn
  • About this site
  • Privacy policy
  • Terms and conditions